Arena Shares Rise After Lief Sees ‘Path Forward’
This article is for subscribers only.
Arena Pharmaceuticals Inc. rose in Nasdaq trading after Chief Executive Officer Jack Lief told investors it’s still possible the company’s experimental diet pill will be cleared for sale.
“We believe we have a path forward to obtain approval of lorcaserin,” Lief said today on a conference call.